CN115715783B - 一种防治猪白痢的中药组合物及其制备方法 - Google Patents
一种防治猪白痢的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN115715783B CN115715783B CN202211689267.7A CN202211689267A CN115715783B CN 115715783 B CN115715783 B CN 115715783B CN 202211689267 A CN202211689267 A CN 202211689267A CN 115715783 B CN115715783 B CN 115715783B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 122
- 241000282887 Suidae Species 0.000 title claims abstract description 60
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- 206010012735 Diarrhoea Diseases 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims description 17
- 239000010231 banlangen Substances 0.000 claims abstract description 37
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 15
- 241000206469 Pulsatilla Species 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 10
- 241000209490 Nymphaea Species 0.000 claims abstract description 4
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 claims abstract description 4
- 229940079593 drug Drugs 0.000 claims description 30
- 241000282898 Sus scrofa Species 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 241000123887 Pulsatilla chinensis Species 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 23
- 238000000605 extraction Methods 0.000 claims description 22
- 239000009636 Huang Qi Substances 0.000 claims description 17
- 239000000287 crude extract Substances 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 108010059892 Cellulase Proteins 0.000 claims description 12
- 229940106157 cellulase Drugs 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- 235000008734 Bergera koenigii Nutrition 0.000 claims description 11
- 240000002393 Murraya koenigii Species 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 10
- 241000601164 Clematis orientalis Species 0.000 claims description 9
- 238000002386 leaching Methods 0.000 claims description 9
- 241000334160 Isatis Species 0.000 claims description 8
- 239000009806 pulsatillae Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 5
- 244000025254 Cannabis sativa Species 0.000 claims description 4
- 241000158764 Murraya Species 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 241000218202 Coptis Species 0.000 claims description 3
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 3
- 241001506304 Kadsura japonica Species 0.000 claims description 2
- 235000016787 Piper methysticum Nutrition 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006186 oral dosage form Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 240000005546 Piper methysticum Species 0.000 claims 1
- 229940107666 astragalus root Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 235000006533 astragalus Nutrition 0.000 abstract description 7
- 241000045403 Astragalus propinquus Species 0.000 abstract description 5
- 240000001899 Murraya exotica Species 0.000 abstract description 3
- 235000008766 Murraya exotica Nutrition 0.000 abstract description 3
- 235000009696 Murraya paniculata Nutrition 0.000 abstract description 3
- 238000009395 breeding Methods 0.000 abstract description 3
- 230000001488 breeding effect Effects 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 38
- 239000008280 blood Substances 0.000 description 38
- 238000012360 testing method Methods 0.000 description 32
- 238000002474 experimental method Methods 0.000 description 18
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 14
- 239000000902 placebo Substances 0.000 description 13
- 229940068196 placebo Drugs 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 10
- 238000001514 detection method Methods 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 7
- 108010082126 Alanine transaminase Proteins 0.000 description 7
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 7
- 229940109239 creatinine Drugs 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 210000000265 leukocyte Anatomy 0.000 description 7
- 210000000440 neutrophil Anatomy 0.000 description 7
- 230000002335 preservative effect Effects 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- 102000001554 Hemoglobins Human genes 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 6
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 6
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 210000003979 eosinophil Anatomy 0.000 description 6
- 230000027939 micturition Effects 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 5
- 108010088751 Albumins Proteins 0.000 description 5
- 239000003651 drinking water Substances 0.000 description 5
- 235000020188 drinking water Nutrition 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000004288 Sodium dehydroacetate Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 210000003651 basophil Anatomy 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000002481 ethanol extraction Methods 0.000 description 4
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 4
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 4
- 235000021050 feed intake Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 229940079839 sodium dehydroacetate Drugs 0.000 description 4
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 4
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical group [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 3
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000218201 Ranunculaceae Species 0.000 description 3
- 241000205578 Thalictrum Species 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 238000004820 blood count Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 229960000740 enrofloxacin Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000005087 mononuclear cell Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 229940068968 polysorbate 80 Drugs 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229940000406 drug candidate Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000003777 experimental drug Substances 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 229930182486 flavonoid glycoside Natural products 0.000 description 2
- 150000007955 flavonoid glycosides Chemical class 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000133570 Berberidaceae Species 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 241000334154 Isatis tinctoria Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 240000007653 Pometia tomentosa Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000021051 daily weight gain Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- OOYIOIOOWUGAHD-UHFFFAOYSA-L disodium;2',4',5',7'-tetrabromo-4,5,6,7-tetrachloro-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [Na+].[Na+].O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(Br)=C([O-])C(Br)=C1OC1=C(Br)C([O-])=C(Br)C=C21 OOYIOIOOWUGAHD-UHFFFAOYSA-L 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 102000014898 transaminase activity proteins Human genes 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
项目 | 空白剂量组 | 1倍剂量组 | 3倍剂量组 | 5倍剂量组 |
白细胞(109/L) | 19.34±3.65 | 19.50±3.08 | 20.33±3.54 | 19.40±5.12 |
红细胞(1012/L) | 5.80±0.48 | 5.54±0.52 | 5.50±0.29 | 5.86±0.25 |
血红蛋白(g/L) | 112.00±10.13 | 113.80±12.32 | 106.90±5.55 | 114.00±6.82 |
血小板(109/L) | 308.60±91.55 | 294.90±48.37 | 266.08±88.22 | 244.90±56.50 |
中性粒细胞(%) | 45.92±8.95 | 43.33±7.77 | 43.05±7.89 | 50.75±7.27 |
嗜酸性细胞(%) | 1.20±0.42 | 1.70±0.82 | 1.70±0.68 | 1.20±0.42 |
嗜碱性细胞(%) | 0.20±0.63 | 0.10±0.32 | 0.20±0.42 | 0.10±0.32 |
淋巴细胞(%) | 48.56±8.19 | 50.16±7.26 | 51.04±9.16 | 44.54±6.88 |
单核细胞(%) | 4.12±2.92 | 4.71±2.59 | 4.01±2.54 | 3.41±2.40 |
项目 | 空白剂量组 | 1倍剂量组 | 3倍剂量组 | 5倍剂量组 |
白细胞(109/L) | 19.12±4.49 | 19.22±0.66 | 21.58±3.57 | 20.90±6.42 |
红细胞(1012/L) | 5.99±0.38 | 6.33±0.17 | 6.08±0.36 | 6.20±0.61 |
血红蛋白(g/L) | 113.20±3.36 | 116.40±3.69 | 115.10±3.48 | 116.90±10.09 |
血小板(109/L) | 296.70±37.29 | 269.00±36.27 | 276.00±51.22 | 370.60±55.56* |
中性粒细胞(%) | 42.29±4.81 | 39.21±6.08 | 38.13±9.67 | 43.79±5.46 |
嗜酸性细胞(%) | 2.00±1.33 | 1.00±0.82* | 1.40±0.70 | 1.10±0.32* |
嗜碱性细胞(%) | 0.30±0.48 | 0.20±0.42 | 0.40±0.52 | 0.30±0.48 |
淋巴细胞(%) | 50.85±4.55 | 54.73±5.55 | 55.00±8.50 | 49.65±4.60 |
单核细胞(%) | 4.56±2.02 | 4.86±1.75 | 5.07±2.47 | 5.16±2.30 |
项目 | 空白剂量组 | 1倍剂量组 | 3倍剂量组 | 5倍剂量组 |
白细胞(109/L) | 16.52±3.15 | 21.22±5.63* | 20.80±4.15 | 16.80±4.95 |
红细胞(1012/L) | 5.68±0.43 | 5.85±0.49 | 6.14±0.45 | 6.39±0.62* |
血红蛋白(g/L) | 110.50±5.64 | 111.40±10.98 | 117.20±9.72 | 120.00±9.44* |
血小板(109/L) | 295.10±79.45 | 321.50±78.70 | 323.50±91.35 | 270.10±92.85 |
中性粒细胞(%) | 43.78±6.05 | 44.46±9.43 | 40.20±10.56 | 40.19±8.03 |
嗜酸性细胞(%) | 1.50±0.53 | 1.80±1.40 | 1.20±1.03 | 1.00±0.82 |
淋巴细胞(%) | 49.58±5.36 | 47.10±9.48 | 51.85±10.37 | 52.57±8.16 |
嗜碱性细胞(%) | 0.80±0.63 | 0.80±1.03 | 1.10±2.18 | 0.60±0.70 |
单核细胞(%) | 4.34±2.54 | 5.84±1.92 | 5.65±3.08 | 5.64±1.78 |
项目 | 空白剂量组 | 1倍剂量组 | 3倍剂量组 | 5倍剂量组 |
总胆红素(μmol/L) | 1.20±0.41 | 0.79±0.35* | 0.93±0.34 | 1.11±0.43 |
总蛋白(g/L) | 46.12±3.75 | 44.20±4.05 | 41.87±3.15* | 44.08±2.78 |
谷丙转氨酶(IU/L) | 54.44±15.21 | 53.60±16.06 | 56.80±16.69 | 53.67±19.33 |
白蛋白(g/L) | 16.30±2.74 | 17.06±4.65 | 15.69±2.23 | 17.22±1.97 |
谷草转氨酶(IU/L) | 82.67±37.54 | 57.89±26.00 | 75.78±28.39 | 61.56±15.15 |
尿素氮(mmol/L) | 3.25±0.51 | 4.27±0.95* | 4.11±0.57* | 3.65±0.79 |
肌酐(μmol/L) | 69.11±8.24 | 71.30±13.45 | 72.10±13.18 | 82.70±11.05* |
血糖(mmol/L) | 5.00±1.25 | 5.31±0.63 | 4.65±1.12 | 5.25±0.96 |
项目 | 空白剂量组 | 1倍剂量组 | 3倍剂量组 | 5倍剂量组 |
总胆红素(μmol/L) | 1.89±0.21 | 1.95±0.43 | 1.72±0.27 | 2.21±0.49 |
总蛋白(g/L) | 45.08±2.31 | 46.11±2.89 | 44.90±3.24 | 45.80±2.02 |
谷丙转氨酶(IU/L) | 47.90±8.23 | 36.50±5.29* | 39.67±9.51 | 41.50±9.00 |
白蛋白(g/L) | 18.07±3.17 | 17.76±2.44 | 16.90±2.17 | 19.21±3.00 |
谷草转氨酶(IU/L) | 50.78±14.78 | 43.63±9.56 | 48.33±15.97 | 40.70±13.75 |
尿素氮(mmol/L) | 2.51±0.58 | 3.73±0.61* | 3.67±0.70* | 2.97±0.68 |
肌酐(μmol/L) | 73.80±8.12 | 83.75±12.12 | 82.56±12.85 | 86.30±12.76* |
血糖(mmol/L) | 5.01±0.49 | 4.38±0.70 | 4.74±1.84 | 4.96±0.91 |
项目 | 空白剂量组 | 1倍剂量组 | 3倍剂量组 | 5倍剂量组 |
总胆红素(μmol/L) | 1.59±0.50 | 1.80±0.43 | 1.53±0.48 | 1.59±0.62 |
总蛋白(g/L) | 47.63±3.44 | 48.49±4.97 | 47.37±3.17 | 48.52±2.78 |
谷丙转氨酶(IU/L) | 39.10±7.64 | 40.10±10.09 | 41.50±9.31 | 48.80±9.26* |
白蛋白(g/L) | 21.40±4.49 | 19.70±3.46 | 20.09±3.73 | 21.68±2.58 |
谷草转氨酶(IU/L) | 38.50±9.28 | 36.60±10.43 | 42.20±18.24 | 44.70±16.87 |
尿素(mmol/L) | 3.15±0.77 | 3.29±1.20 | 3.84±0.85 | 3.57±0.93 |
肌酐(μmol/L) | 77.00±8.06 | 87.20±13.05 | 83.90±10.16 | 88.60±13.23* |
血糖(mmol/L) | 5.27±0.30 | 5.10±1.22 | 5.78±1.07 | 5.17±0.84 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211689267.7A CN115715783B (zh) | 2022-12-27 | 2022-12-27 | 一种防治猪白痢的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211689267.7A CN115715783B (zh) | 2022-12-27 | 2022-12-27 | 一种防治猪白痢的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115715783A CN115715783A (zh) | 2023-02-28 |
CN115715783B true CN115715783B (zh) | 2023-07-25 |
Family
ID=85257836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211689267.7A Active CN115715783B (zh) | 2022-12-27 | 2022-12-27 | 一种防治猪白痢的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115715783B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102308927A (zh) * | 2011-09-09 | 2012-01-11 | 绍兴市辉达生态养殖有限公司 | 防治断奶仔猪腹泻和促生长的中草药添加剂及其应用 |
CN104208294A (zh) * | 2013-09-29 | 2014-12-17 | 郑州后羿制药有限公司 | 一种用于治疗仔猪黄白痢的中药组合物及其制备方法 |
CN107693594A (zh) * | 2017-10-23 | 2018-02-16 | 四川巴尔动物药业有限公司 | 一种治疗畜禽腹泻的中兽药组合物及其制备方法 |
-
2022
- 2022-12-27 CN CN202211689267.7A patent/CN115715783B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102308927A (zh) * | 2011-09-09 | 2012-01-11 | 绍兴市辉达生态养殖有限公司 | 防治断奶仔猪腹泻和促生长的中草药添加剂及其应用 |
CN104208294A (zh) * | 2013-09-29 | 2014-12-17 | 郑州后羿制药有限公司 | 一种用于治疗仔猪黄白痢的中药组合物及其制备方法 |
CN107693594A (zh) * | 2017-10-23 | 2018-02-16 | 四川巴尔动物药业有限公司 | 一种治疗畜禽腹泻的中兽药组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
中草药添加剂防治断奶仔猪腹泻和促生长效果试验;朱志刚;胡建刚;章华其;周其兵;周六江;蒋云香;尹小良;;浙江畜牧兽医;-(02);第27-28页 * |
止泻灵防治猪腹泻病的临床试验;王自然;中兽医学杂志;-(03);第11页 * |
Also Published As
Publication number | Publication date |
---|---|
CN115715783A (zh) | 2023-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105410346A (zh) | 提高养殖对虾存活率的中药制剂及其制备方法 | |
CN106924477B (zh) | 一种混合菌发酵生产的复合中药发酵制剂及其制备方法 | |
CN104208294B (zh) | 一种用于治疗仔猪黄白痢的中药组合物及其制备方法 | |
CN115715783B (zh) | 一种防治猪白痢的中药组合物及其制备方法 | |
CN115381915B (zh) | 一种治疗痰热瘀结型肺结节的中药组合物、其制备方法和应用 | |
CN111358850B (zh) | 一种用于防治鸡大肠杆菌病的中药组合物及其制备方法 | |
CN104721337B (zh) | 一种预防和治疗鸡大肠杆菌病的中药组合物及其制备方法和应用 | |
CN111588801B (zh) | 一种预防畜禽疫病的中药分散颗粒剂及其制备方法 | |
CN110559415B (zh) | 一种提高雏禽育成率的天然植物复方制剂及其制备方法和应用 | |
CN109432287B (zh) | 一种防治家禽气分热盛证的中药口服液及其制备方法 | |
CN113975357A (zh) | 清肺化痰、消痈排脓、清热利湿的中药组合物及其应用 | |
CN103417653B (zh) | 一种治疗球虫的兽用复方纯中药及其口服液的制备方法 | |
CN114601882A (zh) | 一种用于提高鱼类生长性能的中草药微生态制剂的制备方法 | |
CN101314033A (zh) | 一种用于家畜、家禽及水产动物的疫苗口服液增效剂及其制备方法 | |
CN115919951B (zh) | 一种中药组合物及其制备方法和应用 | |
CN115607614B (zh) | 一种治疗畜禽大肠杆菌病的中药组合物及其制备方法 | |
CN104922530A (zh) | 一种防治鸡大肠杆菌病的药物组合物及其制备方法 | |
CN116270896B (zh) | 一种治疗畜禽咳嗽的中药物组合物及其制备方法 | |
CN111544570B (zh) | 一种添加抗菌肽的抗病毒制剂及其制备方法 | |
CN115006496B (zh) | 一种治疗狐貉貂肺炎的中草药组合物 | |
CN105169327B (zh) | 一种治疗猪腹泻疾病的药物组合物及其制备方法 | |
CN109350661B (zh) | 一种止咳化痰的发酵中药组合物及其在防治猪呼吸道疾病中的应用 | |
CN115487250B (zh) | 一种用于防治非洲猪瘟的中药组合物及其制备方法和应用 | |
CN108743693A (zh) | 一种仔猪保健促生长中药组合物、制备方法及其应用 | |
CN115721677B (zh) | 用于防治犊牛细菌性腹泻的中药组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: No. 9, Yugang Road, Airport Economic Comprehensive Experimental Zone, Zhengzhou City, Henan Province, 451162 Patentee after: HENAN MUXIANG BIOTECHNOLOGY Co.,Ltd. Country or region after: China Address before: No. 9, Yugang Road, Airport Economic Comprehensive Experimental Zone, Zhengzhou, Henan 450000 Patentee before: HENAN SOAR VETERINARY PHARMACEUTICAL Co.,Ltd. Country or region before: China Patentee before: HENAN MUXIANG BIOTECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address |